Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
about
Natriuretic peptides for acute heart failureNatriuretic peptides for acute heart failureCardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signalingAcute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Organ-specific responses to circulatory disturbances in heart failure: new insightsCurrent strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approachEfficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trialsChallenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugsAngiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyondStimulation of soluble guanylyl cyclase protects against obesity by recruiting brown adipose tissueRationale and design of a randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy of B-type natriuretic peptide for the preservation of left ventricular function after anterior myocardial infarctionOutcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentSilent disease progression in clinically stable heart failure.Effects of Low-Dose Recombinant Human Brain Natriuretic Peptide on Anterior Myocardial Infarction Complicated by Cardiogenic Shock.Chronic heart failure: contemporary diagnosis and managementInnovative Therapeutics: Designer Natriuretic Peptides.Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiativeUse of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure.Short-term mortality and cost associated with cardiac device implantation in patients hospitalized with heart failure.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Importance of venous congestion for worsening of renal function in advanced decompensated heart failure.Nesiritide in acute decompensated heart failure: current status and future perspectivesTolvaptan: the evidence for its therapeutic value in acute heart failure syndromeA retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide.Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.Genetic and nongenetic factors influencing pharmacokinetics of B-type natriuretic peptide.Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.Renal subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): the end of nesiritide as a cardiorenal therapeutic?The cardiorenal syndrome: making the connection.Relation of worsened renal function during hospitalization for heart failure to long-term outcomes and rehospitalization.Pulmonary hypertension secondary to left ventricular systolic dysfunction: contemporary diagnosis and managementCardiorenal syndrome in acute heart failure syndromes.Current treatment options for early management in acute decompensated heart failure.Emergency cardiology: a review of recent literature.Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applicationsCardiorenal Syndrome: The Clinical Cardiologists' Perspective.Genetic variation in the natriuretic peptide system and heart failure.Update of acute kidney injury: intensive care nephrology.Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review
P2860
Q24194433-A4A9840F-5667-4C4C-A295-EC4B06781A27Q24245105-744F1DB1-9183-478F-9771-E1D7F1915EEDQ24629099-66E3CBBB-D52A-4E02-B0D1-0DFA56E719A6Q26745670-1E04462E-972F-4CAD-B0F2-333C11741A15Q26822738-8FB073E1-6C67-4126-A4FA-3E34013594D7Q26822842-E888A170-158B-4EFD-B86C-7ADCF178DB41Q28078389-700454F4-DAC5-4B92-B895-DF08EE40F4AAQ28085736-8E7241FC-1AD3-48EA-8044-ECDD9EAA6313Q28088583-59A0806F-546D-44D3-9E96-4DF17665711AQ30316523-06F75FE3-1098-4509-8CF4-AB844A7BA7C1Q30433780-C0BC4566-50B4-4D44-BDD8-740F502CC667Q33307212-C57A5018-2A17-4A0E-9257-6F1C7299547BQ33573360-0A086FEC-E42F-4895-92F3-99A8304E938FQ33578212-A489DD91-0A93-4516-A126-45EE01ADDB8DQ33615284-88CB3DD8-65AA-4AE0-B487-009A3F009396Q33620431-E685BC14-8E97-4E35-A572-3AF1B975F18CQ33653332-D4829F6A-F15E-4D1E-BD43-60CB27458335Q33728260-5AEACC2E-44F6-44F6-9BCC-713642474283Q33735342-AF7CD5A6-66A3-4A89-9ED3-F4BE2BABDA13Q33735354-708FF8DC-68F5-4DC5-A8F1-9AFA517B964FQ33753500-9EFD84CF-28E5-4108-83D5-3BD8E43244E6Q33799478-2FBA4438-11DB-41CD-985E-B045B98313F6Q33878162-D273605B-F664-4188-B56C-0C7D61F537A4Q33973976-23106416-46F0-4193-AF5F-0FA98D53302EQ34069726-81F09EDD-D239-4D0E-8654-031ECF8C2EEAQ34127995-6BEB8AAF-C8B5-4D16-BC82-6B17729C4BC2Q34304189-0862C74F-889A-473C-B280-A6738EB6988EQ34305164-80054209-1864-4323-80D5-B6D539CFF552Q34334888-6288F581-6712-4013-9C43-D43DB8BAC1A0Q34340391-D0368E99-DF8F-4907-B8C1-4BFBA2C05C5EQ34470304-3FA2B959-FD2A-4990-8F8C-14EA6F781D6FQ34525179-83B6B996-B09C-41A3-BC8E-1F65249C81DDQ34665867-2DD68F97-5E60-46E7-8E44-A34DB1D74E94Q34796529-DC8720B7-BA91-4330-97BF-79A4C1CE6568Q34808230-EB03E9CD-6B19-4D29-9301-95365E268364Q34906050-3F9BF1A5-D96C-4633-93B9-3DD42520512FQ35005376-94EBDEF3-501C-4454-8EB7-FF14E9251C79Q35046791-72D929FC-4530-4735-99CF-B63CEBA41E66Q35115570-EFA1A716-7BBD-4506-91B7-DEF47A6E6890Q35132420-9F484189-DF44-4195-BABE-7F8077E17E44
P2860
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of worsening renal functi ...... y decompensated heart failure.
@ast
Risk of worsening renal functi ...... y decompensated heart failure.
@en
Risk of worsening renal functi ...... y decompensated heart failure.
@nl
type
label
Risk of worsening renal functi ...... y decompensated heart failure.
@ast
Risk of worsening renal functi ...... y decompensated heart failure.
@en
Risk of worsening renal functi ...... y decompensated heart failure.
@nl
prefLabel
Risk of worsening renal functi ...... y decompensated heart failure.
@ast
Risk of worsening renal functi ...... y decompensated heart failure.
@en
Risk of worsening renal functi ...... y decompensated heart failure.
@nl
P2093
P1433
P1476
Risk of worsening renal functi ...... y decompensated heart failure.
@en
P2093
Hal A Skopicki
Jonathan D Sackner-Bernstein
Keith D Aaronson
P304
P356
10.1161/01.CIR.0000159340.93220.E4
P407
P577
2005-03-21T00:00:00Z